These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Benzyl isothiocyanate ameliorates high-fat/cholesterol/cholic acid diet-induced nonalcoholic steatohepatitis through inhibiting cholesterol crystal-activated NLRP3 inflammasome in Kupffer cells. Chen HW, Yen CC, Kuo LL, Lo CW, Huang CS, Chen CC, Lii CK. Toxicol Appl Pharmacol; 2020 Apr 15; 393():114941. PubMed ID: 32126212 [Abstract] [Full Text] [Related]
3. Cathepsin B inhibition ameliorates the non-alcoholic steatohepatitis through suppressing caspase-1 activation. Tang Y, Cao G, Min X, Wang T, Sun S, Du X, Zhang W. J Physiol Biochem; 2018 Nov 15; 74(4):503-510. PubMed ID: 30019185 [Abstract] [Full Text] [Related]
5. Sweroside Prevents Non-Alcoholic Steatohepatitis by Suppressing Activation of the NLRP3 Inflammasome. Yang G, Jang JH, Kim SW, Han SH, Ma KH, Jang JK, Kang HC, Cho YY, Lee HS, Lee JY. Int J Mol Sci; 2020 Apr 17; 21(8):. PubMed ID: 32316419 [Abstract] [Full Text] [Related]
6. Cardiolipin inhibitor ameliorates the non-alcoholic steatohepatitis through suppressing NLRP3 inflammasome activation. Liu J, Wang T, He K, Xu M, Gong JP. Eur Rev Med Pharmacol Sci; 2019 Sep 17; 23(18):8158-8167. PubMed ID: 31599445 [Abstract] [Full Text] [Related]
7. Ezetimibe ameliorates steatohepatitis via AMP activated protein kinase-TFEB-mediated activation of autophagy and NLRP3 inflammasome inhibition. Kim SH, Kim G, Han DH, Lee M, Kim I, Kim B, Kim KH, Song YM, Yoo JE, Wang HJ, Bae SH, Lee YH, Lee BW, Kang ES, Cha BS, Lee MS. Autophagy; 2017 Oct 03; 13(10):1767-1781. PubMed ID: 28933629 [Abstract] [Full Text] [Related]
8. Exercise suppresses NLRP3 inflammasome activation in mice with diet-induced NASH: a plausible role of adropin. Yang W, Liu L, Wei Y, Fang C, Liu S, Zhou F, Li Y, Zhao G, Guo Z, Luo Y, Li L. Lab Invest; 2021 Mar 03; 101(3):369-380. PubMed ID: 33268842 [Abstract] [Full Text] [Related]
10. Fatty acid activates NLRP3 inflammasomes in mouse Kupffer cells through mitochondrial DNA release. Pan J, Ou Z, Cai C, Li P, Gong J, Ruan XZ, He K. Cell Immunol; 2018 Oct 03; 332():111-120. PubMed ID: 30103942 [Abstract] [Full Text] [Related]
13. Restraint stress promotes nonalcoholic steatohepatitis by regulating the farnesoid X receptor/NLRP3 signaling pathway. Yang F, Lv XT, Lin XL, Wang RH, Wang SM, Wang GE. Acta Biochim Biophys Sin (Shanghai); 2023 Dec 25; 55(12):1961-1971. PubMed ID: 37997375 [Abstract] [Full Text] [Related]
14. CXCL5 promotes lipotoxicity of hepatocytes through upregulating NLRP3/Caspase-1/IL-1β signaling in Kupffer cells and exacerbates nonalcoholic steatohepatitis in mice. Qi J, Yan X, Li L, Qiu K, Huang W, Zhou Z. Int Immunopharmacol; 2023 Oct 25; 123():110752. PubMed ID: 37573690 [Abstract] [Full Text] [Related]
15. The TIR/BB-loop mimetic AS-1 prevents non-alcoholic steatohepatitis and hepatic insulin resistance by inhibiting NLRP3-ASC inflammasome activation. Wang X, Gao Y, Song J, Tang C, Wang M, Que L, Liu L, Zhu G, Chen Q, Yao Y, Xu Y, Li J, Li Y. Br J Pharmacol; 2017 Jun 25; 174(12):1841-1856. PubMed ID: 28306139 [Abstract] [Full Text] [Related]